Loss of neurofibromin function through germline NF1 mutations predisposes to a spectrum of tumors and hamartomas, most notably plexiform neurofibromas and optic pathway gliomas (OPGs), with the latter occurring in roughly 15-20% of children with NF1 and causing visual loss in a subset [6]. This evidence concerns the gene NF1 and plexiform neurofibroma.